Impact of Triclosan on Female Reproduction through Reducing Thyroid Hormones to Suppress Hypothalamic Kisspeptin Neurons in Mice.
Cao. Xin-Yuan XY; Hua. Xu X; Xiong. Jian-Wei JW; Zhu. Wen-Ting WT; Zhang. Jun J; Chen. Ling L
Key Findings
- Triclosan exposure (≥10 mg/kg) reduces T3/T4 thyroid hormones and raises TSH, TRH, and prolactin.
- Lower thyroid hormones suppress kisspeptin expression in the AVPV and ARC, leading to reduced LH/FSH and disrupted estrous cycles.
- Treatments that restore thyroid hormone (L‑T4), block prolactin (quinpirole), or directly activate kisspeptin receptors (kisspeptin‑10) rescue kisspeptin levels and normalize reproductive hormones and cycling.
Practical Outcomes
- For biohackers, the take‑away is to minimize triclosan exposure (e.g., avoid certain soaps and toothpaste) and keep thyroid function optimal, as thyroid disruption can impair fertility via kisspeptin pathways. While kisspeptin‑10 shows promise in mice, it isn’t a ready‑to‑use supplement for humans yet.
Summary
In mice, the antimicrobial chemical triclosan lowered thyroid hormones, which caused a rise in prolactin and shut down kisspeptin signals in the brain. This chain reaction messed up the hormones that control ovulation and stopped normal menstrual cycles. Giving the mice thyroid hormone (levothyroxine), a dopamine‑type drug, or the peptide kisspeptin‑10 fixed the kisspeptin drop and restored fertility hormones.
Abstract
Triclosan (TCS), a broad-spectrum antimicrobial agent, is widely used in clinical settings and various personal care products. The aim of this study was to evaluate the influence of TCS on reproductive endocrine and function. Here, we show that the exposure of adult female mice to 10 or 100 mg/kg/day TCS caused prolongation of diestrus, and decreases in antral follicles and corpora lutea within 2 weeks. TCS mice showed decreases in the levels of serum luteinizing hormone (LH), follicle-stimulating hormone (FSH) and progesterone, and gonadotrophin-releasing hormone (<i>GnRH</i>) mRNA with the lack of LH surge and elevation of prolactin (PRL). TCS mice had lower kisspeptin immunoreactivity and <i>kiss1</i> mRNA in anteroventral periventricular nucleus (AVPV) and arcuate nucleus (ARC). Moreover, the estrogen (E2)-enhanced AVPV-kisspeptin expression was reduced in TCS mice. In addition, the serum thyroid hormones (triiodothyronine (T3) and thyroxine (T4)) in TCS mice were reduced with increases in levels of thyroid stimulating hormone (TSH) and thyroid releasing hormone (TRH). In TCS mice, the treatment with Levothyroxine (L-T4) corrected the increases in PRL, TSH and TRH; the administration of L-T4 or type-2 dopamine receptors agonist quinpirole inhibiting PRL release could rescue the decline of kisspeptin expression in AVPV and ARC; the treatment with L-T4, quinpirole or the GPR45 agonist kisspeptin-10 recovered the levels of serum LH and FSH and progesterone, and <i>GnRH</i> mRNA. Furthermore, TCS mice treated with L-T4 or quinpirole resumed regular estrous cycling, follicular development and ovulation. Together, these results indicate that exposing adult female mice to TCS (≥10 mg/kg) reduces thyroid hormones causing hyperprolactinemia that then suppresses hypothalamic kisspeptin expression, leading to deficits in reproductive endocrine and function.
Study Information
pubmed
2018
2018-01-19T00:00:00.000Z
10.3389/fnmol.2018.00006
33
69